Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/TRAVERE-THERAPEUTICS-INC-15458731/news/Travere-Therapeutics-startet-pivotale-klinische-Phase-3-Studie-mit-Pegtibatinase-zur-Behandlung-der-45574037/?utm_source=whatsapp&utm_medium=social&utm_campaign=share